A non-clinical comparative study of IL-23 antibodies in psoriasis

Four antibodies that inhibit interleukin (IL)-23 are approved for the treatment of moderate-to-severe plaque psoriasis. Here, we present non-clinical data comparing ustekinumab, guselkumab, tildrakizumab and risankizumab with regard to thermostability, IL-23 binding affinity, inhibitory-binding mode...

Full description

Saved in:
Bibliographic Details
Main Authors: Li Zhou (Author), Yibing Wang (Author), Qi Wan (Author), Fei Wu (Author), Jeffrey Barbon (Author), Robert Dunstan (Author), Stephen Gauld (Author), Mark Konrad (Author), Laura Leys (Author), Richard McCarthy (Author), Marian Namovic (Author), Christine Nelson (Author), Gary Overmeyer (Author), Denise Perron (Author), Zhi Su (Author), Leyu Wang (Author), Susan Westmoreland (Author), Jun Zhang (Author), Rui Zhu (Author), Geertruida Veldman (Author)
Format: Book
Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available